4 Results for "

H1437

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "H1437" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-18707
CAS No.: 1469337-95-8
Target:  

Ras Apoptosis

Research Areas:  

Cancer

K-Ras(G12C) inhibitor 12 is an irreversible inhibitor of K-Ras(G12C). K-Ras(G12C) inhibitor 12 can alter the nucleotide-binding preference of K-Ras and block its interaction with effector proteins. K-Ras(G12C) inhibitor 12 can reduce cell viability and induce apoptosis in lung cancer cell lines with G12C mutations. K-Ras(G12C) inhibitor 12 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-106381
CAS No.: 12244-57-4
Purity:  ≥98.0%
Target:  

PKC NF-κB TrxR

Research Areas:  

Inflammation/Immunology Cancer

Aurothiomalate sodium acts as an inhibitor of PKCI and TrxR1. Aurothiomalate sodium disrupts the PKCI-Par6-Rac1 signaling pathway, and also inhibits TrxR1 activity, TNFα-induced NF-κB activation, and the expression of pro-inflammatory genes. Aurothiomalate sodium blocks Kras-mediated BASC expansion and lung tumor growth, inhibits anchorage-independent growth and tumorigenicity of lung cancer cells, and suppresses neutrophil chemotaxis, phagocytosis, and leukocyte extravasation. Aurothiomalate sodium can be used in research related to rheumatoid arthritis and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-177893
CAS No.: 3048497-38-4
Target:  

PROTACs c-Met/HGFR

Research Areas:  

Cancer

OZD-MET 01 is a chaperone-med iatedprotein PROTAC-type MET degrader. OZD-MET 01 can inhibit proliferation of H596 and H1437 cells with IC50 values of 3.07 and 3.5 μM. OZD-MET 01 can be used for the research of cancer, such as non-small cell lung cancer . (Structure Note: Pink: MET ligand (HY-50878); Blue: chaperone ligand (HY-112078); MET ligand-Linker: (HY-176950))
loading...
    loading...
Cat. No.: HY-W010270A
CAS No.: 74916-57-7
Target:  

PKC NF-κB TrxR

Research Areas:  

Inflammation/Immunology Cancer

Aurothiomalate disodium acts as an inhibitor of PKCI and TrxR1. Aurothiomalate disodium disrupts the PKCI-Par6-Rac1 signaling pathway, and also inhibits TrxR1 activity, TNFα-induced NF-κB activation, and the expression of pro-inflammatory genes. Aurothiomalate disodium blocks Kras-mediated BASC expansion and lung tumor growth, inhibits anchorage-independent growth and tumorigenicity of lung cancer cells, and suppresses neutrophil chemotaxis, phagocytosis, and leukocyte extravasation. Aurothiomalate disodium can be used in research related to rheumatoid arthritis and non-small cell lung cancer .
loading...
    loading...